Search all medical codes

Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel

HCPCS code

Name of the Procedure:

Common Names: COVID-19 Test, Coronavirus Test, SARS-CoV-2 Test
Technical Term: CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (U0001)

Summary

This procedure is a diagnostic test used to detect the presence of the virus that causes COVID-19 (SARS-CoV-2) using a molecular testing method called real-time reverse transcription-polymerase chain reaction (RT-PCR). The test identifies viral RNA, indicating an active infection.

Purpose

The primary purpose of the COVID-19 RT-PCR test is to confirm whether someone is currently infected with SARS-CoV-2. This helps in diagnosing COVID-19, thereby enabling timely medical intervention and appropriate public health measures to control the spread of the virus.

Indications

  • Symptoms such as fever, cough, shortness of breath, and loss of taste or smell.
  • Close contact with a confirmed COVID-19 case.
  • High-risk exposure settings (healthcare, travel, large gatherings).
  • Pre-surgical or hospital admission screening.

Preparation

  • No specific preparation is required for most patients.
  • Inform the healthcare provider of any recent travel history or contact with COVID-19-positive individuals.
  • Some testing sites may require an appointment and pre-registration.

Procedure Description

  1. Specimen Collection: A healthcare professional will use a swab to collect a sample from the patient’s nasal cavity, throat, or both.
  2. Transportation: The specimen is placed in a sterile container and transported to a laboratory.
  3. Laboratory Analysis: The lab uses RT-PCR technology to amplify and detect viral RNA from the sample.
  4. Reporting: Results are typically available within 24 to 72 hours and reported to the patient or their healthcare provider.

Duration

The sample collection takes about 5 to 10 minutes. Laboratory analysis and results reporting typically take between 1 to 3 days.

Setting

  • The swab collection can be performed in various settings, including hospitals, outpatient clinics, drive-through testing sites, and specialized testing centers.

Personnel

  • Sample collection is usually performed by a trained healthcare worker such as a nurse or medical technician.
  • Laboratory scientists and technicians handle the analysis in specialized labs.

Risks and Complications

  • Common Risks: Mild discomfort or gagging during throat swab, minor irritation or soreness in the nasal cavity.
  • Rare Risks: Nosebleeds or minor infections at the swab site.

Benefits

  • Early detection of COVID-19 allows for timely treatment and isolation to prevent virus spread.
  • Accurate diagnosis aids in monitoring and managing outbreaks.

Recovery

  • No recovery time is needed post-procedure.
  • Continued self-monitoring for symptoms and adherence to public health advice (e.g., isolation if positive).

Alternatives

  • Antigen Tests: Faster but less sensitive.
  • Antibody Tests: Not for active infection, used to detect past exposure.
  • Rapid Molecular Tests: Provide quicker results but may have higher rates of false negatives compared to standard RT-PCR.

Patient Experience

  • During the swab, patients may feel momentary discomfort or pressure in the nasal cavity or throat.
  • Post-procedure, patients can continue with regular activities unless symptomatic or instructed to isolate based on the result.
  • Results are communicated to the patient, and if positive, guidelines for quarantine and contact tracing are provided. Pain management and comfort measures are typically not necessary for this procedure.

Medical Policies and Guidelines for Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel

Related policies from health plans

Similar Codes